Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics Inc.
WKN: A3DS0P / Symbol: SLNO / Name: Soleno Therapeutics / Aktie / Micro Cap /
36,96 €
-2,17 %
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $8.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $19.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Oppenheimer Holdings Inc. from $8.00 to $14.00. They now have an "outperform" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Cantor Fitzgerald from $19.00 to $35.00. They now have an "overweight" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $40.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Oppenheimer Holdings Inc. from $44.00 to $47.00. They now have an "outperform" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $63.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $93.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $65.00 to $59.00. They now have an "outperform" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Soleno Therapeutics, Inc. (NASDAQ: SLNO) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Ratings data for SLNO provided by MarketBeat
Neueste Beiträge
StockNews_com in Digital Ally Inc. diskutieren, Digital Ally Inc.new